Search
Now showing items 1-10 of 66
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group
Hoechstetter, Manuela A. et al. (2020)
Wissenschaftlicher Artikel
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials
Kaddu-Mulindwa, Dominic et al. (2022)
Wissenschaftlicher Artikel
Interleukin-10 receptor signaling promotes the maintenance of a PD-1(i)(nt) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity
Hanna, Bola S. et al. (2021)
Wissenschaftlicher Artikel
Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of "MYC-negative" Burkitt lymphoma
Wagener, Rabea et al. (2020)
Wissenschaftlicher Artikel
BIRC3 mutations in chronic lymphocytic leukemia - uncommon and unfavorable
Tausch, Eugen; Stilgenbauer, Stephan (2020)
Wissenschaftlicher Artikel
Combining ibrutinib and checkpoint blockade improves CD8(+) T-cell function and control of chronic lymphocytic leukemia in E mu-TCL1 mice
Hanna, Bola S. et al. (2021)
Wissenschaftlicher Artikel
Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study
Davids, Matthew S. et al. (2020)
Wissenschaftlicher Artikel
Discovery of Candidate DNA Methylation Cancer Driver Genes
Pan, Heng et al. (2021)
Wissenschaftlicher Artikel
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Byrd, John C. et al. (2021)
Wissenschaftlicher Artikel
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
Cramer, Paula et al. (2021)
Wissenschaftlicher Artikel